Hair Restoration, Hormone Therapy, and Peptides: What You Should Know This Week

By Dr. Amitha Parvataneni

TL;DR

• This week's FDA peptide hearing is reviewing whether several once-banned peptides, marketed online for anti-aging, muscle recovery, and weight loss, including two we offer in our own supervised program, BPC-157 and Mots-C, should be allowed back into compounding pharmacies. The FDA's own scientists are recommending against it, citing missing safety and efficacy data.[1][2][3]
• Yes, we offer BPC-157 and Mots-C, two of the exact peptides named in this week's hearing, but only through a real consultation, responsible sourcing, and ongoing physician monitoring, never as a self-directed online purchase.
• The same philosophy, personalized and physician-supervised over generic and gray-market, is why I built my hormone replacement therapy program the way I did, after living it myself as a patient before I ever treated one.[9]
• Our TED hair restoration approach uses an FDA-cleared device to deliver a topical peptide and growth-factor blend to the scalp, in our office, under physician supervision, a separate offering from our peptide program.
• We hold ourselves to the same standard this week's hearing is asking the peptide industry to meet: be honest about what the evidence actually shows, not just what sounds promising, whether that is a peptide, a device, or hormone therapy.

In This Article

1. What's Actually Happening at the FDA This Week
2. Why "Peptide" Is Not One Thing
3. Inside Our Physician-Supervised, Peptide-Inclusive Approach to Hair Restoration
4. Yes, We Also Offer BPC-157 and Mots-C, and Here Is Why That Is Different
5. Why Physician-Supervised Hormone Therapy Follows the Same Rule
6. What We Will Do, and What We Won't
7. Frequently Asked Questions
8. Research Appendix

If you saw the headlines this week about the FDA peptide hearing, you may have felt a small jolt of worry. Maybe you have been thinking about hair restoration, or hormone replacement therapy, and you noticed that some of what we offer touches the word "peptide" too. You saw a serious word in the news, and now you are wondering if it applies to you.

That is a completely fair question to ask. You should ask it. And if you already know we offer some of the very peptides named in this week's news elsewhere in our practice, you may have an even more direct question. I want to answer that one too, not dodge it.

Here is what I want you to know before you read any further. Physician-supervised care and the gray-market peptides at the center of this week's news are not the same conversation, even when they share a word or even a compound. I want to walk you through exactly what is happening in Washington this week, and exactly what we do differently in this office, whether you are here for hair restoration, hormone therapy, or a peptide, so you can tell the two apart for yourself.

What's Actually Happening at the FDA This Week

This week's FDA peptide hearing, held by an advisory committee called the Pharmacy Compounding Advisory Committee, is a two-day meeting reviewing seven peptides, all marketed online for uses like anti-aging, muscle recovery, and weight loss, including two peptides we offer through our own supervised program, BPC-157 and Mots-C.[1][2][3] These peptides were pulled from the list of substances compounding pharmacies can legally prepare back in 2023, in what is often called the 2023 peptide ban, after regulators found the safety data too thin to support their use.[1][4]

Now the committee is deciding whether to let compounding pharmacies make them again. The FDA's own career scientists reviewed the evidence ahead of the meeting and are recommending against it. Their review of these compounded peptides found the data comes mostly from animal and lab studies, with very little research in actual humans.[1][2]

Dr. Eric Topol, a cardiologist and founder of the Scripps Research Translational Institute, framed the core problem simply: what is missing is the safety data, the efficacy data, and the kind of critical evidence physicians rely on before recommending any treatment.[1] Other experts have raised a related concern, that at the wrong dose, certain peptides could promote unwanted cell growth or trigger an immune reaction.[2]

There is also a fairness question in the room. The advisory committee reviewing these peptides has 19 members, and unusually, 6 of them work for or run businesses that sell or dispense peptides.[1] That does not automatically make the committee wrong. It does mean you, as a patient, are right to want a second, more careful look before trusting any peptide product marketed to you directly, including, honestly, from us.

Why "Peptide" Is Not One Thing

Here is the part that gets lost in a headline. "Peptide" is not a single product. It is a category, the same way "medication" is a category. Insulin is a peptide. Some of the most effective weight-loss drugs available today, like tirzepatide and semaglutide, are peptides.[1][2] Those went through years of rigorous testing before they reached your pharmacy.

The peptides in this week's hearing are a different situation. They are compounded, meaning a pharmacy mixes them, and in most cases, when purchased outside a physician's care, they are self-injected at home after being sourced through channels with little to no independent testing for purity or accurate dosing.

Two of our own offerings, TED hair restoration and our peptide program, also use this word. I understand exactly why that gives a careful patient pause. So let me tell you specifically what that means in our office, not in general.

Inside Our Physician-Supervised, Peptide-Inclusive Approach to Hair Restoration

TED stands for TransEpidermal Delivery. It is an FDA-cleared device, not a compounded injectable drug.[6] Think of your scalp's outer layer like a screen door. Most topical products can only sit on top of it. TED uses gentle ultrasound and air pressure to briefly and safely open tiny channels in that layer, so a topical blend, one that includes peptides and growth factors, can actually reach the follicle instead of sitting on the surface.[6]

Nothing about this is self-injected. Nothing is sourced from an online research-chemical seller. The treatment happens here, in our office, applied by our team, under my supervision as your physician. A typical course is three sessions spaced about a month apart, and most patients notice fuller, thicker-looking hair somewhere in the three-to-six-month range.[6][7]

I want to be just as honest with you about TED as I am about anything else I offer. The clinical evaluations behind it are real, but they are still early. One small evaluation of 33 patients found meaningful increases in hair density at six months, and a separate small study of 10 patients reported similar improvements with no adverse effects.[7][8] These are encouraging early results, not a guarantee, and I will tell you that directly rather than let a headline number do the talking. That is the same standard I wish more of the peptide industry held itself to this week.

It suits early to moderate thinning, in both men and women. Whether it is the right option for you depends on your specific pattern of hair loss, which is exactly what a consultation is for.

Yes, We Also Offer BPC-157 and Mots-C, and Here Is Why That Is Different

You may already know that BPC-157 and Mots-C, two of the exact peptides named in this week's hearing, are also part of our own physician-supervised peptide program.[1][2] I would rather address that directly than let you wonder about it while reading the rest of this article.

We do offer them. What matters is how.

Every peptide patient starts with a real consultation before anything is prescribed, not a checkout cart. We source responsibly rather than through an anonymous online seller shipping a vial with no prescription attached. And I monitor how you respond over time, the same way I would with any other treatment I prescribe, adjusting your protocol as needed rather than handing you a fixed dose and stepping away.

I want to be exactly as honest with you about these peptides as I am about everything else in this article. In the wellness world, BPC-157 is often discussed for inflammation and recovery, and Mots-c for metabolism and energy. Patients understandably ask us directly: is BPC-157 safe? The honest answer is that the human research behind it, and behind Mots-C, is still developing. I am not going to tell you either one is proven to treat a specific condition, because that would overstate exactly the kind of evidence gap this week's FDA hearing itself is highlighting.[1][2]

What I will tell you is this. If you are already considering a peptide, whether it is one of these or another, doing it through a physician who examines you first, sources responsibly, and stays involved for the duration is a fundamentally safer path than ordering a vial online with no oversight at all. That is not a marketing line. It is the actual safety argument sitting at the center of this week's hearing, applied to your own decision.

Why Physician-Supervised Hormone Therapy Follows the Same Rule

Everything in this article so far comes down to one question. Is a treatment personalized and physician-supervised, or is it generic and gray-market? Nowhere in my own practice is that question more personal to me than hormone replacement therapy.

Long before I was a hormone-therapy physician, I was a hormone-therapy patient. I have written directly about that experience, the exhaustion, the brain fog, and the mistake of generic dosing before I finally found a personalized protocol that worked for my own body.[9] That experience is exactly why I do not hand any hormone therapy patient a one-size-fits-all starting dose either.

Every hormone replacement therapy patient here starts with real lab work, not a standard starter kit. We build your plan around your own results, then monitor and adjust over a structured three-to-four month process to find what actually stabilizes your body.[9] And just as with TED and our peptide program, I will tell you plainly where the hormone therapy research is strong and where it is still developing, rather than oversell you on a headline claim.[9]

If hormone therapy is the more pressing question for you right now, the first step is a virtual HRT consultation, a real conversation with me by video, not a generic online questionnaire or a compounding order placed without ever speaking to a physician.

What We Will Do, and What We Won't

We will start with a real evaluation of you, not a guess. We will build a plan around your specific goals and history, not a one-size protocol pulled from an online forum. Where a device is involved, as with TED, we use one that is FDA-cleared and administered by our team. Where a peptide or a hormone is involved, as with our peptide program and hormone replacement therapy, we source responsibly and monitor you over time.

We will not sell you an unregulated peptide off the shelf. We will not tell you a treatment is guaranteed to work before we have actually examined you. And we will not stay quiet about what the research does and does not yet show, even when a more dramatic claim might be easier to sell.

If you have read my thoughts on my own HRT journey, this will sound familiar.[9] I feel exactly the same way about generic dosing and internet trends there as I do about hair restoration and peptides here. Personalized, physician-monitored care is not a slogan in this practice. It is the only way I know how to practice medicine responsibly.

Frequently Asked Questions

Are the peptides in this week's FDA peptide hearing safe and legal to use right now? As of this week, the peptides under review, including BPC-157 and Mots-C, remain restricted from pharmacy compounding under the FDA's 2023 safety determination, which is exactly what this hearing is reconsidering.[1][2] The FDA's own scientists say the safety and efficacy evidence is still too limited to draw a firm conclusion either way. Because the regulatory picture is genuinely in flux, the more useful question for a patient is not just "is it legal," but "is whoever is providing it doing so responsibly," with real medical oversight rather than an unsupervised online purchase.

Is BPC-157 legal? BPC-157 is one of the specific peptides this week's FDA hearing is reconsidering, after being restricted from compounding-pharmacy production in 2023.[1][2] Rather than treating that as a simple yes-or-no answer, we think the more responsible question is how a peptide reaches you: through a physician who examines you, sources responsibly, and monitors your response, or through an anonymous seller with no oversight at all.

Are the peptides in this week's FDA news the same ones used in TED hair restoration? Not quite. Two of the peptides under FDA review this week, BPC-157 and Mots-C, are also offered through our separate, physician-supervised peptide program, described above.[1] The topical formula used with TED hair restoration is a different product entirely: it is delivered by an FDA-cleared device, applied in our office, not injected. TED and our peptide program serve different purposes and are administered in different ways.

Does ASMD offer BPC-157 or Mots-C? Yes, as part of our physician-supervised peptide program. Every patient starts with a consultation, sourcing goes through responsible channels rather than an anonymous online seller, and I monitor your response over time. I will always be honest that the human evidence behind these specific peptides is still developing, which is exactly the concern driving this week's FDA hearing.[1][2]

Is TED hair restoration peptide treatment safe? TED itself is an FDA-cleared, non-invasive device, and the small clinical evaluations conducted so far reported no adverse events.[7][8] As with any treatment, safety also depends on whether it is the right fit for your specific hair loss pattern, which is why we start every new hair-restoration patient with a real consultation rather than booking treatment sight unseen.

How is TED hair restoration in Troy, MI different from what I'd find online? Everything happens in person, in our office, with a device that is FDA-cleared and administered by trained staff under my supervision. There is no self-injection, no unregulated sourcing, and no guessing at dosing. You also get an actual evaluation first, so we can tell you honestly whether this is likely to help your specific situation.

Do you offer a virtual HRT consultation? Yes. Our virtual HRT consultation is a video visit with me to review your symptoms, history, and whether hormone replacement therapy may be the right next step for you, the same starting point I once went through myself as a patient.[9] It is billed separately from hair restoration, and because it is genuinely virtual, you can complete it from wherever you are before any lab work or in-person visit.

Research Appendix

• [1] Jewett, Christina and Dana G. Smith. "A Peptide Showdown: F.D.A. Scientists May Clash With Kennedy's Agenda." The New York Times, July 23, 2026.
• [2] Stone, Will. "Peptides get their regulatory close-up." NPR/KPBS Public Media, July 22, 2026.
• [3] "FDA Panel to Revisit Biden Peptide Ban as It Weighs Looser Rules." Bloomberg Law, July 21, 2026.
• [4] Glenza, Jessica. "FDA to discuss easing restrictions on peptides despite safety concerns." The Guardian, June 26, 2026.
• [5] "FDA Peptide Advisory Panel Faces Questions About Members' Potential Conflicts of Interest." TheAdviserMagazine, July 22, 2026.
• [6] U.S. Food and Drug Administration, 510(k) Premarket Notification Database. "Alma TED+ System," K251684, Alma Lasers, Inc., decision date June 5, 2026, device class II. FDA 510(k) record.
• [7] Bauman, DiBernardo B, Desai S. "A 6-Month Dual-Center Study Evaluating Alma TED and a Peptide-Based Topical Hair Care Formula for Female and Male Pattern Hair Loss." Manufacturer-supported clinical evaluation, N=33. White paper.
• [8] DiBernardo B, Dy L, Desai S. "Transepidermal Delivery With a Proprietary Low-Frequency Ultrasound: A New Novel Treatment Option for Androgenetic Alopecia?" Clinical evaluation, N=10. Clinical evaluation.
• [9] Parvataneni, Amitha. "When the Doctor Becomes the Patient: How My Own HRT Journey Changed Everything." ASM.D. Aesthetics, July 15, 2026.

A Question Worth Asking, However You Answer It

You do not need a medical degree to ask good questions about what goes into your body. This week's news is actually a good reminder to ask those questions of anyone offering you a peptide product, or any treatment at all, including us.

I can only speak for what happens in this office. Every hair-restoration patient, every peptide patient, and every hormone therapy patient starts with a real evaluation, a real plan, and a physician who stays involved. That will not change no matter what a committee in Washington decides this week.

To find out whether physician-supervised, TED hair restoration is right for you, schedule an in-person consultation with Dr. Amitha Parvataneni at ASMD Aesthetics.

Call us: (313) 949-0418
Learn more about hair restoration: asmdaesthetics.com/hair-restoration
Book your free TED consultation online: Schedule here

If hormone replacement therapy is the more pressing question for you, start with a virtual HRT consultation, from wherever you are.

Book your virtual HRT consultation online: Schedule here
Read more from Dr. Parvataneni on her own HRT journey: When the Doctor Becomes the Patient